Amgen will lay off a small number employees from Dublin-headquartered Horizon Therapeutics next year, after closing its $27.8bn (€26.3bn) acquisition of the rare-disease drugmaker earlier this ...
The agency gave Akebia’s drug an OK after receiving more safety data, but imposed a strict boxed warning for its use that may limit uptake.
Arrakis Therapeutics parted ways with about 20% of its workforce last week. CEO Michael Gilman confirmed the layoffs to the Business Journal on Monday, writing in an emailed statement that the ...
Two months after closing its multibillion-dollar acquisition of Mirati Therapeutics, Bristol Myers Squibb is bidding adieu to ...
Pfizer announced Tuesday it would lay off up to 800 researchers, according to a report from 'The Wall Street Journal.' Pfizer expects to have laid off 5% to 8% of its 10,000-person research staff ...
Amgen is arguably one of the most impressive companies in its industry. The pharma giant topped the analyst consensus for both revenue and non-GAAP EPS in Q4. Amgen's debt is rated investment ...
Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach and tens of thousands of employees belie its humble origins. Founded in 1980 as Applied ...
Amgen still needs to show that the reduction in Lp(a) is accompanied by lower rates of cardiovascular outcomes, and will endeavour to show that in its phase 3 programme which will start to enrol ...
At Argus Research, Jasper covers the Growth Pharmaceutical, Medical Technology, and Financial Technology companies. He received his undergraduate degree from Boston University, graduating cum ...
ANNOUNCER: 'Think Tank' has been made possible by Amgen, arecipient of the Presidential National Medal of Technology. Amgen,bringing better, healthier lives to people worldwide throughbiotechnology.
The national debt is over $34 trillion, consumer credit card debt is a staggering $1.13 trillion, and many companies ...
The Artificial Intelligence rally over the last year, led by the so-called “Magnificent 7,” has been fantastic if you owned those stocks. However, most of the S&P 500 is treading water and ...